Afmedica Inc. acquired by Angiotech Pharmaceuticals Inc.
|
|
|
|
|
developing perivascular technology using the drug rapamycin to treat peripheral vascular disease; coronary artery disease and end stage renal disease | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|